Creo Medical has announced an update on progress and trading during Q1/21, noting trading ahead of expectations based upon strong contributions from the acquisitions made during 2020 and increased commercial activity from Creo's core devices. We have upgraded our forecasts following this announcement. The company notes a quick return to pre-COVID levels of activity as elective procedures have restarted to tackle surgery backlogs. This announcement follows the full-year trading update provided in ....
19 May 2021
Cenkos: Creo Medical Group Plc -- Trading update and upgrade
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Cenkos: Creo Medical Group Plc -- Trading update and upgrade
Creo Medical Group Plc (CREO:LON) | 35.5 0.1 1.0% | Mkt Cap: 128.3m
- Published:
19 May 2021 -
Author:
Chris Donnellan -
Pages:
8
Creo Medical has announced an update on progress and trading during Q1/21, noting trading ahead of expectations based upon strong contributions from the acquisitions made during 2020 and increased commercial activity from Creo's core devices. We have upgraded our forecasts following this announcement. The company notes a quick return to pre-COVID levels of activity as elective procedures have restarted to tackle surgery backlogs. This announcement follows the full-year trading update provided in ....